Log in to save to my catalogue

A comparative randomized open label study to evaluate efficacy, safety and cost effectiveness betwee...

A comparative randomized open label study to evaluate efficacy, safety and cost effectiveness betwee...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_2243cfb13f7b4bc991212237bbcc701a

A comparative randomized open label study to evaluate efficacy, safety and cost effectiveness between topical 2% sertaconazole and topical 1% butenafine in tinea infections of skin

About this item

Full title

A comparative randomized open label study to evaluate efficacy, safety and cost effectiveness between topical 2% sertaconazole and topical 1% butenafine in tinea infections of skin

Publisher

India: Medknow Publications and Media Pvt. Ltd

Journal title

Indian journal of dermatology, 2013-11, Vol.58 (6), p.451-456

Language

English

Formats

Publication information

Publisher

India: Medknow Publications and Media Pvt. Ltd

More information

Scope and Contents

Contents

Dermatophytoses are the superficial fungal infections of skin, hair, and nail. Butenafine is a benzylamine group of antifungal that inhibits the biosynthesis of ergosterol by blocking squalene epoxidase. Sertaconazole is a newer imidazole antifungal which inhibits the biosynthesis of ergosterol by inhibiting 14-α lanosterol demethylase. The study w...

Alternative Titles

Full title

A comparative randomized open label study to evaluate efficacy, safety and cost effectiveness between topical 2% sertaconazole and topical 1% butenafine in tinea infections of skin

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_2243cfb13f7b4bc991212237bbcc701a

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_2243cfb13f7b4bc991212237bbcc701a

Other Identifiers

ISSN

0019-5154

E-ISSN

1998-3611

DOI

10.4103/0019-5154.119955

How to access this item